Literature DB >> 18725140

Management of malignant biliary obstruction.

Karen T Brown1, Anne M Covey.   

Abstract

Malignant bile duct obstruction is not uncommon, particularly in the later stages of disease, and may result in significant deterioration in the patient's quality of life, particularly if the patient becomes pruritic. Patients who have undergone previous intervention such as surgery with bilioenteric bypass, sphincterotomy, or endoscopic retrograde cholangiopancreatography may present with cholangitis. In addition, obstructive jaundice may preclude the use of certain chemotherapeutic agents either because of increased toxicity or because they require hepatic metabolism or excretion. This article discusses the indications for drainage in this patient population, technical considerations that may be unique to this patient population, and technical suggestions for performing drainage that may be helpful.

Entities:  

Mesh:

Year:  2008        PMID: 18725140     DOI: 10.1053/j.tvir.2008.05.005

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  9 in total

Review 1.  To stent or not to stent: an evidence-based approach to palliative procedures at the end of life.

Authors:  Sydney M Dy; Stephanie M Harman; Ursula K Braun; Lynn J Howie; Patricia F Harris; Robert L Jayes
Journal:  J Pain Symptom Manage       Date:  2012-04       Impact factor: 3.612

2.  Malignant biliary obstructions: can we predict immediate postprocedural cholangitis after percutaneous biliary drainage?

Authors:  Shin Ahn; Yoon-Seon Lee; Kyung Soo Lim; Jae-Lyun Lee
Journal:  Support Care Cancer       Date:  2013-03-26       Impact factor: 3.603

3.  Cholangitis prevention in endoscopic Klatskin tumor palliation: air cholangiography technique.

Authors:  Franco Pisello; Girolamo Geraci; Giuseppe Modica; Carmelo Sciumè
Journal:  Langenbecks Arch Surg       Date:  2009-08-26       Impact factor: 3.445

4.  Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction.

Authors:  Dimitrios Karnabatidis; Stavros Spiliopoulos; Paraskevi Katsakiori; Odissefs Romanos; Konstantinos Katsanos; Dimitrios Siablis
Journal:  World J Hepatol       Date:  2013-03-27

5.  Clinical epidemiology and outcomes of biliary tract infections caused by Klebsiella pneumoniae.

Authors:  Lanyu Li; Changqing Zhu; Huan Huang
Journal:  Ann Transl Med       Date:  2019-07

6.  The efficacy of endoscopic palliation of obstructive jaundice in hepatocellular carcinoma.

Authors:  Semi Park; Jeong Youp Park; Moon Jae Chung; Jae Bock Chung; Seung Woo Park; Kwang-Hyub Han; Si Young Song; Seungmin Bang
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

7.  Cost Analysis of Biliary Drainage Using Metal versus Plastic Stents in Hepatocellular Carcinoma Patients with Obstructive Jaundice.

Authors:  Esam Elshimi; Wesam Morad
Journal:  Gastrointest Tumors       Date:  2019-11-01

8.  One-channel double stent implantation for hilar biliary obstructions.

Authors:  Guangshao Cao; Huicun Cao; Jian Liu; Yudan Wang; Zhenyu Wang
Journal:  Exp Ther Med       Date:  2013-01-23       Impact factor: 2.447

9.  Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice.

Authors:  Guang Yuan Zhang; Wen Tao Li; Wei Jun Peng; Guo Dong Li; Xin Hong He; Li Chao Xu
Journal:  Oncol Lett       Date:  2014-02-07       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.